Brief: Vivesto Signs Agreement With US Contract Research Services Provider
19/04/2022 06:11
April 19 (Reuters) - Vivesto AB VIVE.ST :
* VIVESTO SIGNS AGREEMENT WITH LEADING US CRO TO EVALUATE
ANTI-CANCER DRUG FORMULATIONS USING ITS PROPRIETARY DRUG
DELIVERY PLATFORMS
* SIGNED A RESEARCH AGREEMENT WITH VISIKOL INC., A LEADING
U.S.
CONTRACT RESEARCH SERVICES PROVIDER (CRO)
* VISIKOL WILL CONDUCT RESEARCH TO EVALUATE CELLULAR EFFECTS
OF
NEW AND EXISTING ANTI-CANCER DRUG FORMULATIONS DEVELOPED USING
VIVESTO'S PROPRIETARY XR-17™ AND XR-18 TECHNOLOGIES
Source text for Eikon: ID:nMFN1hFGLp
Further company coverage: VIVE.ST
(Gdansk Newsroom)
((gdansk.newsroom@thomsonreuters.com; +48 58 7696600;))